Explore

Learn about the facts and myths around epilepsy and the different forms it can take.
  • BrainFacts/SfN
As genetic sequencing becomes more affordable and the number of families seeking answers grow, neuroscientists make a discovery that could lead to treatments.
  • BrainFacts/SfN
Around one in 10,000 infants are born with SMA. Research funding and patient advocacy efforts helped push treatment into existence.
  • BrainFacts/SfN
The risks of antidepressants during pregnancy are minimal — and they pale in comparison to the risks of not treating depression.
  • BrainFacts/SfN
The first new antidepressant medication in decades, ketamine is a game changer for depression treatment.
  • BrainFacts/SfN
  • 5 min
A small battery-sized device implanted into the chest delivering small zaps of electricity to the vagus nerve can make a huge impact in a patient’s wellbeing.
  • BrainFacts/SfN
Neuroscientist Denise Bellinger explains vagus nerve stimulation, its history as a medical treatment, and whether commercial VNS devices are effective and safe.
  • BrainFacts/SfN
AI programs assist clinicians in surfacing signs of depression through patient data.
  • BrainFacts/SfN
Chance observations in the 1950s prompted scientists to hypothesize that low neurotransmitter levels cause depression. That thinking has unraveled.
  • Knowable Magazine
The fast-acting drug offers a new way to treat depression and fathom its origins. Recent approval of a nasal spray promises to expand access, but much remains unknown.
  • Knowable Magazine
Serendipitous findings in the 1950s spawned the idea that depression was a “chemical imbalance” in the brain. But decades of research — and a radical new treatment — are upending that thinking.
  • BrainFacts/SfN
Bacterial infections can make their way to the brain, where they can linger undetected.
  • BrainFacts/SfN